Generic Industry Will Need Strategies Beyond Core Business for “Post-80%” Era: JGA President

JGA President Mitsuo Sawai Generic drug makers will need to develop business strategies for after the domestic generic volume share reaches 80%, said Mitsuo Sawai, president of the Japan Generic Medicines Association (JGA) in a recent interview with Jiho, predicting...read more